UK biotechnology company, SkyePharma, saw its share price jump almost 10% on the London Stock Exchange this morning after its revealed it has received an unsolicited bid approach and will now consider "all its strategic options," including selling the firm.
Now, who........?
Source: PharmaTimes
No comments:
Post a Comment